Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315574171> ?p ?o ?g. }
- W4315574171 endingPage "252" @default.
- W4315574171 startingPage "252" @default.
- W4315574171 abstract "Prostate cancer is the most diagnosed malignancy in men in the United States and the second leading cause of cancer-related death. For localized disease, radiation therapy is a standard treatment that is often curative. For metastatic disease, radiation therapy has been primarily used for palliation, however, several newer systemic radiation therapies have been demonstrated to significantly improve patient outcomes and improve survival. In particular, several targeted radionuclide therapies have been approved for the treatment of advanced-stage cancer, including strontium-89, samarium-153, and radium-223 for bone-metastatic disease, and lutetium-177-labeled PSMA-617 for patients with prostate-specific membrane antigen (PSMA)-expressing metastatic castration-resistant prostate cancer (mCRPC). Contrarily, immune-based treatments have generally demonstrated little activity in advanced prostate cancer, with the exception of the autologous cellular vaccine, sipuleucel-T. This has been attributed to the presence of an immune-suppressive prostate cancer microenvironment. The ability of radiation therapy to not only eradicate tumor cells but also potentially other immune-regulatory cells within the tumor immune microenvironment suggests that targeted radionuclide therapies may be well poised to combine with immune-targeted therapies to eliminate prostate cancer metastases more effectively. This review provides an overview of the recent advances of targeted radiation agents currently approved for prostate cancer, and those being investigated in combination with immunotherapy, and discusses the challenges as well as the opportunities in this field." @default.
- W4315574171 created "2023-01-11" @default.
- W4315574171 creator A5021686685 @default.
- W4315574171 creator A5022819825 @default.
- W4315574171 creator A5070521827 @default.
- W4315574171 creator A5090284376 @default.
- W4315574171 date "2023-01-11" @default.
- W4315574171 modified "2023-10-02" @default.
- W4315574171 title "Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer" @default.
- W4315574171 cites W1520988368 @default.
- W4315574171 cites W1536264784 @default.
- W4315574171 cites W1540792390 @default.
- W4315574171 cites W1602207043 @default.
- W4315574171 cites W1788773500 @default.
- W4315574171 cites W1835835741 @default.
- W4315574171 cites W1959227906 @default.
- W4315574171 cites W1963575875 @default.
- W4315574171 cites W1965617754 @default.
- W4315574171 cites W1977316337 @default.
- W4315574171 cites W1979811833 @default.
- W4315574171 cites W1984266465 @default.
- W4315574171 cites W1988258076 @default.
- W4315574171 cites W1988998405 @default.
- W4315574171 cites W1989377456 @default.
- W4315574171 cites W1997610387 @default.
- W4315574171 cites W1999020268 @default.
- W4315574171 cites W2002847955 @default.
- W4315574171 cites W2005958584 @default.
- W4315574171 cites W2007658730 @default.
- W4315574171 cites W2011204537 @default.
- W4315574171 cites W2025421597 @default.
- W4315574171 cites W2026920720 @default.
- W4315574171 cites W2035636047 @default.
- W4315574171 cites W2039536878 @default.
- W4315574171 cites W2040659915 @default.
- W4315574171 cites W2052727153 @default.
- W4315574171 cites W2053703796 @default.
- W4315574171 cites W2059473785 @default.
- W4315574171 cites W2062313368 @default.
- W4315574171 cites W2068476226 @default.
- W4315574171 cites W2071365490 @default.
- W4315574171 cites W2078369748 @default.
- W4315574171 cites W2081463541 @default.
- W4315574171 cites W2085471307 @default.
- W4315574171 cites W2087829832 @default.
- W4315574171 cites W2091546879 @default.
- W4315574171 cites W2092393050 @default.
- W4315574171 cites W2092776013 @default.
- W4315574171 cites W2101889062 @default.
- W4315574171 cites W2103959341 @default.
- W4315574171 cites W2105337740 @default.
- W4315574171 cites W2105949723 @default.
- W4315574171 cites W2107002488 @default.
- W4315574171 cites W2108079275 @default.
- W4315574171 cites W2112859081 @default.
- W4315574171 cites W2113510389 @default.
- W4315574171 cites W2117089606 @default.
- W4315574171 cites W2121637327 @default.
- W4315574171 cites W2122950582 @default.
- W4315574171 cites W2127707619 @default.
- W4315574171 cites W2127901889 @default.
- W4315574171 cites W2139046481 @default.
- W4315574171 cites W2144827656 @default.
- W4315574171 cites W2145829662 @default.
- W4315574171 cites W2146629016 @default.
- W4315574171 cites W2149951991 @default.
- W4315574171 cites W2155033435 @default.
- W4315574171 cites W2160069559 @default.
- W4315574171 cites W2160406420 @default.
- W4315574171 cites W2170731023 @default.
- W4315574171 cites W2171451762 @default.
- W4315574171 cites W2172218341 @default.
- W4315574171 cites W2226193240 @default.
- W4315574171 cites W2411910056 @default.
- W4315574171 cites W2419138985 @default.
- W4315574171 cites W2463707297 @default.
- W4315574171 cites W2465092116 @default.
- W4315574171 cites W2467018059 @default.
- W4315574171 cites W2488621988 @default.
- W4315574171 cites W2501712293 @default.
- W4315574171 cites W2523396458 @default.
- W4315574171 cites W2531934133 @default.
- W4315574171 cites W2594458360 @default.
- W4315574171 cites W2606187374 @default.
- W4315574171 cites W2618173228 @default.
- W4315574171 cites W2622587024 @default.
- W4315574171 cites W2732447270 @default.
- W4315574171 cites W2753764866 @default.
- W4315574171 cites W2753771069 @default.
- W4315574171 cites W2761681010 @default.
- W4315574171 cites W2768547115 @default.
- W4315574171 cites W2775321189 @default.
- W4315574171 cites W2788909438 @default.
- W4315574171 cites W2799931007 @default.
- W4315574171 cites W2800232471 @default.
- W4315574171 cites W2895593497 @default.
- W4315574171 cites W2896329607 @default.
- W4315574171 cites W2906673642 @default.